Evaluating the Ability of 99mTc-Tilmanocept to Identify Clipped Nodes in Breast Cancer Patients Undergoing Neoadjuvant Chemotherapy and Sentinel Lymph Node Dissection
Status: TERMINATED
Study type: OBSERVATIONAL
Conditions: Breast Cancer
Interventions: DRUG: 99m Tc-TM
Sponsor: Johns Hopkins University
Collaborators: Cardinal Health